Open House: Challenges to SMEs and Startups with Clinical Trials in Medical Devices

Are you gearing up for a clinical trial in the next 12-18 months and seeking expert guidance? Join us at the Cicada HealthTech Hub Open House for an evening of insights and networking. 

This is your opportunity to meet with experts in running and setting up a med device clinical trial, get answers to those questions, and walk away with a better understanding of the next steps to take.

Whether you're close to initiating your trial or still laying the groundwork, this event is designed to clarify the clinical trial process and address your immediate queries. You'll also have the option to take a guided tour of our HealthTech Hub facilities.

Meet the Panel:

	Kate Donald, Partner, Corrs Chambers Westgarth (IP Legal)
	Jeremy Kwarcinski, Co-Founder, iiShield
	Stefan Czyniewski, Principal, Mobius Medical (CRO)
	Nicolette Muller, Principal Consultant, QA/RA Dynamics (Reg. Affairs)
	Morgan James, IDE Director Drug Delivery Systems Group & IDE Manufacturing (Design & Manufacturing)

Event Agenda:

4:30 - Registration, Networking, drinks and canapés
5:15 - Panel Discussion & Q&A
6:15 - Networking drinks and canapés 
6:30 - Event ends

Don't miss this opportunity to connect with experts and fellow founders in the clinical trial ecosystem. Join us at the Cicada HealthTech Hub Open House and take the first step towards a successful clinical trial journey.

About The Cicada HealthTech Hub

The Cicada HealthTech Hub is home to early stage health companies, a space for collaboration and commercialisation activation, and a landing pad for industry seeking solutions to their research and business challenges.

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.

The Cicada Health Tech Hub will deliver several new health-focused program alongside Australasia’s leading life science VC firm, Brandon Capital.


Find out more about the Cicada Health Tech Hub